Novo Nordisk Statistics

Total Valuation

Novo Nordisk has a market cap or net worth of DKK 4.16 trillion. The enterprise value is 4.15 trillion.

Market Cap	4.16T
Enterprise Value	4.15T

Important Dates

The next estimated earnings date is Wednesday, November 6, 2024.

Earnings Date	Nov 6, 2024
Ex-Dividend Date	Aug 15, 2024

Share Statistics

Novo Nordisk has 4.43 billion shares outstanding. The number of shares has decreased by -0.90% in one year.

Shares Outstanding	4.43B
Shares Change (YoY)	-0.90%
Shares Change (QoQ)	-0.11%
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	33.40%
Float	3.17B

Valuation Ratios

The trailing PE ratio is 46.71 and the forward PE ratio is 36.53. Novo Nordisk's PEG ratio is 1.59.

PE Ratio	46.71
Forward PE	36.53
PS Ratio	16.23
PB Ratio	37.16
P/FCF Ratio	51.25
PEG Ratio	1.59

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 32.48, with an EV/FCF ratio of 51.18.

EV / Earnings	46.20
EV / Sales	16.10
EV / EBITDA	32.48
EV / EBIT	35.01
EV / FCF	51.18

Financial Position

The company has a current ratio of 0.94, with a Debt / Equity ratio of 50.71.

Current Ratio	0.94
Quick Ratio	0.74
Debt / Equity	50.71
Debt / EBITDA	0.45
Debt / FCF	0.70
Interest Coverage	218.77

Financial Efficiency

Return on equity (ROE) is 88.57% and return on invested capital (ROIC) is 51.87%.

Return on Equity (ROE)	88.57%
Return on Assets (ROA)	22.80%
Return on Capital (ROIC)	51.87%
Revenue Per Employee	3.73M
Profits Per Employee	1.30M
Employee Count	64,319
Asset Turnover	0.79
Inventory Turnover	1.24

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +45.67% in the last 52 weeks. The beta is 0.13, so Novo Nordisk's price volatility has been lower than the market average.

Beta (5Y)	0.13
52-Week Price Change	+45.67%
50-Day Moving Average	929.56
200-Day Moving Average	848.69
Relative Strength Index (RSI)	56.42
Average Volume (20 Days)	2,713,362

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novo Nordisk had revenue of DKK 258.00 billion and earned 89.90 billion in profits. Earnings per share was 20.08.

Revenue	258.00B
Gross Profit	218.09B
Operating Income	118.57B
Pretax Income	112.93B
Net Income	89.90B
EBITDA	126.56B
EBIT	118.57B
Earnings Per Share (EPS)	20.08

Full Income Statement

Balance Sheet

The company has 62.65 billion in cash and 57.06 billion in debt, giving a net cash position of 5.59 billion or 1.26 per share.

Cash & Cash Equivalents	62.65B
Total Debt	57.06B
Net Cash	5.59B
Net Cash Per Share	1.26
Equity (Book Value)	112.52B
Book Value Per Share	25.24
Working Capital	-10.41B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 115.33 billion and capital expenditures -34.18 billion, giving a free cash flow of 81.16 billion.

Operating Cash Flow	115.33B
Capital Expenditures	-34.18B
Free Cash Flow	81.16B
FCF Per Share	18.30

Full Cash Flow Statement

Margins

Gross margin is 84.53%, with operating and profit margins of 45.96% and 34.84%.

Gross Margin	84.53%
Operating Margin	45.96%
Pretax Margin	43.77%
Profit Margin	34.84%
EBITDA Margin	49.05%
EBIT Margin	45.96%
FCF Margin	31.46%

Dividends & Yields

This stock pays an annual dividend of 9.40, which amounts to a dividend yield of 1.02%.

Dividend Per Share	9.40
Dividend Yield	1.02%
Dividend Growth (YoY)	39.93%
Years of Dividend Growth	6
Payout Ratio	46.71%
Buyback Yield	0.90%
Shareholder Yield	1.92%
Earnings Yield	2.14%
FCF Yield	1.95%

Dividend Details

Stock Splits

The last stock split was on September 13, 2023. It was a forward split with a ratio of 2.

Last Split Date	Sep 13, 2023
Split Type	Forward
Split Ratio	2